Security key
89422GAA5
- Type / Class
- Debt / NOTE 2.250% 3/0
- Market price (% of par)
- 142.2%
- Total 13F principal
- $316,740,000
- Principal change
- +$44,363,646
- Total reported market value
- $451,855,340
- Number of holders
- 33
- Value change
- +$76,789,651
- Number of buys
- 20
- Number of sells
- 12
Report period
Q4 2025
Institutions
33
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 89422GAA5
Recent filing periods:
Top shareholders of 89422GAA5 - TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0 as of Q4 2025
As of 31 Dec 2025,
TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0 was held by
33 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$316,740,000
in principal (par value) of the bond.
The largest 10 bondholders included
Linden Advisors LP, Context Capital Management, LLC, D. E. Shaw & Co., Inc., FMR LLC, MILLENNIUM MANAGEMENT LLC, ADVENT CAPITAL MANAGEMENT /DE/, TENOR CAPITAL MANAGEMENT Co., L.P., LORD, ABBETT & CO. LLC, Affinity Asset Advisors, LLC, and SHENKMAN CAPITAL MANAGEMENT INC.
This page lists
33
institutional bondholders reporting positions
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price (% of par) | Principal | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
29
Q4 2025 holders
33
Holder diff
4
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.